Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 5/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATP2A2 | P16615 | 1/20 | 0.38 |
| ▸ | ATP2A3 | Q93084 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9006900 | 0.85 | GABRA1 (0.41) | GABRA1GABRB2ALDH1A1ALOX15MAPT | |
| SCHEMBL60651 | 0.74 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2TYRCYP2C9CA2 | |
| SCHEMBL150439 | 0.74 | GABRA1 (0.43) | GABRA1GABRB2ALDH1A1ALOX15MAPT | |
| SCHEMBL11707700 | 0.72 | TSHR (0.37) | ALDH1A1TSHR | |
| SCHEMBL7722741 | 0.72 | — | — | |
| SCHEMBL2821369 | 0.72 | ACHE (0.39) | ALDH1A1ALOX15MAPTCYP1A2KDM4E | |
| SCHEMBL2395901 | 0.70 | ALDH1A1 (0.40) | GABRA1GABRB2ALDH1A1ALOX15MAPT | |
| SCHEMBL27854953 | 0.70 | ALDH1A1 (0.43) | GABRA1GABRB2ALDH1A1ALOX15MAPT | |
| SCHEMBL5414773 | 0.70 | — | — | |
| SCHEMBL8391443 | 0.70 | HPN (0.33) | ALOX15MAPTHPNSIRT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170298058-A1 | HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE | SHIONOGI & CO (JP) | 2017-10-19 | — | — | US | claimed |
| EP-2604260-B1 | NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SHIONOGI & CO (JP) | 2017-05-10 | — | — | EP | claimed |
| US-20160024072-A1 | Heterocyclic Ring and Carbocyclic Derivative | SHIONOGI & CO., LTD. (JP) | 2016-01-28 | — | — | US | claimed |
| US-20130225596-A1 | NOVEL HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME (AS AMENDED) | SHIONOGI & CO., LTD. (JP) | 2013-08-29 | — | — | US | claimed |
| EP-2604260-A1 | NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Shionogi&Co., Ltd. (JP) | 2013-06-19 | — | — | EP | claimed |
| US-7402589-B2 | Tri-substituted ureas as cytokine inhibitors | THE PROCTER & GAMBLE COMPANY (US) | 2008-07-22 | — | — | US | claimed |
| US-7323511-B2 | Post-coupling synthetic approach for polymeric antioxidants | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2008-01-29 | — | — | US | claimed |
| US-20070299072-A1 | KV1.5 POTASSIUM CHANNEL INHIBITORS | WYETH (US) | 2007-12-27 | — | — | US | claimed |
| EP-1846460-A2 | POST-COUPLING SYNTHETIC APPROACH FOR POLYMERIC ANTIOXIDANTS | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2007-10-24 | — | — | EP | claimed |
| EP-1737830-A1 | TRI-SUBSTITUTED UREAS AS CYTOKINE INHIBITORS | The Procter and Gamble Company (US) | 2007-01-03 | — | — | EP | claimed |
| WO-2005105757-A1 | TRI-SUBSTITUTED UREAS AS CYTOKINE INHIBITORS | THE PROCTER & GAMBLE COMPANY (US) | 2005-11-10 | — | — | WO | claimed |
| US-20050245555-A1 | Tri-substituted ureas as cytokine inhibitors | THE PROCTER & GAMBLE COMPANY (US) | 2005-11-03 | — | — | US | claimed |
| US-20050238789-A1 | Post-coupling synthetic approach for polymeric antioxidants | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2005-10-27 | — | — | US | claimed |
| WO-2005070974-A2 | POST-COUPLING SYNTHETIC APPROACH FOR POLYMERIC ANTIOXIDANTS | UNIVERSITY OF MASSACHUSETTS LOWELL (US) | 2005-08-04 | — | — | WO | claimed |
| US-5332529-A | Dielectric fluids and electrodes | TEXACO INC. (US) | 1994-07-26 | — | — | US | claimed |
| US-20170298058-A1 | HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE | SHIONOGI & CO (JP) | 2017-10-19 | — | — | US | disclosed |
| EP-2604260-B1 | NOVEL HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SHIONOGI & CO (JP) | 2017-05-10 | — | — | EP | disclosed |
| US-5089656-A | Forming a phenoxide intermediate, adding an aprotic solvent and an acrylate | HIMONT INCORPORATED (US) | 1992-02-18 | — | — | US | disclosed |
| EP-0467063-A2 | Process for the preparation of aryl-substituted propionic acid esters | Himont Incorporated (US) | 1992-01-22 | — | — | EP | disclosed |
| EP-0272588-A1 | Acetylene diurea derivatives and their use in stabilizing synthetic resins | BASF Aktiengesellschaft (DE) | 1988-06-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170298058-A1 | HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE | P2RX3, P2RX7, P2RX2 | GABRA1 245/4885GABRB2 192/4885ALDH1A1 2515/4885 |
| US-20050245555-A1 | Tri-substituted ureas as cytokine inhibitors | IL1B, IL1A, IL6 | GABRA1 3746/4885GABRB2 3533/4885ALDH1A1 455/4885 |
| US-20160024072-A1 | Heterocyclic Ring and Carbocyclic Derivative | P2RX3, P2RX7, P2RX2 | GABRA1 245/4885GABRB2 192/4885ALDH1A1 2515/4885 |
| US-20130225596-A1 | NOVEL HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME (AS AMENDED) | P2RX3, P2RX6, P2RX2 | GABRA1 379/4885GABRB2 320/4885ALDH1A1 2598/4885 |
| US-20070299072-A1 | KV1.5 POTASSIUM CHANNEL INHIBITORS | KCNA5, KCNH1, KCNK5 | GABRA1 571/4885GABRB2 806/4885ALDH1A1 888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.